Invion (AU:IVX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Invion Limited has appointed Professor Robert Ramsay, a leading expert in cancer biology, as its Scientific Advisor to guide its clinical trials and research programs. Ramsay’s expertise, particularly with Invion’s lead cancer drug candidate INV043, is expected to enhance the company’s efforts in advancing Photodynamic Therapy for cancer treatment. This strategic move aligns with Invion’s mission to develop life-changing therapies and address unmet needs in patient care.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.
